Post-approval studies (Phase 4)Not Yet RecruitingNCT07537088
What this trial is testing
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
Who this might be right for
T2DM (Type 2 Diabetes Mellitus)CKD - Chronic Kidney Disease
First Affiliated Hospital of Wannan Medical College 468